The Biden administration is putting pharmaceutical companies on notice, warning them that if the price of certain drugs is too high, the government might cancel their patent protection and allow rivals to make their own versions.
The Court of Appeals of Indiana is considering a challenge to the state’s near total abortion ban on grounds it violates a religious freedom law.
The biggest U.S. drugstore chain aims to make the payment system more transparent by using a formula based on a drug’s cost, a fixed markup, and a fee that reflects the value of the pharmacy services, the company said Tuesday.
Dr. Leonard Dale Guyer has been the subject of controversy several times over the past two decades.
The company, Carmot Therapeutics, has numerous drugs under development. Its lead asset is a once-a-week injection that is in mid-stage development for the treatment of obesity.
The agreement hammered out with state and local governments and victims would provide billions of dollars to combat the opioid epidemic. The decision also has implications for other major product liability lawsuits settled through the bankruptcy system.
An estimated 130,000 Hoosiers over the age of 60 using Medicaid will receive notices in early 2024 advising them to choose a Managed Care Entity to coordinate their health coverage.
The move follows pushback by several neighborhood groups on the north side who expressed concern about the city’s plan, which could rely heavily on the Midtown tax-increment financing district to repay bonds issued for the acquisition.
Some warn that the spiraling number of deals could lead to large physician groups having an unfairly high market share, which could lead to price increases and cost-cutting.
The extension comes amid pushback from several investors, including Point’s largest institutional stock holder.
If trends continue, as many as 30 million people could end up being dropped from Medicaid. The numbers dwarf the Biden administration’s initial projections.
The business makes a hand-sanitizing device called Iggy that kills pathogens with ozone-infused water instead of soap or other chemicals.
The interim Health Care Cost Oversight Task Force unanimously agreed on a final report Monday detailing seven recommended legislative proposals for the upcoming session.
Point has a pipeline of clinical and preclinical-stage compounds in development for the treatment of cancer using radiopharmaceutical isotopes that hold the promise of delivering targeted treatments to cancer patients.
Lilly’s lepodisiran, given at the highest dose, reduced a heart disease-linked protein to undetectable levels for 48 weeks, according to the study.
Almost a year after distributions started from the National Opioid Settlement, only $7.1 million has been put to use so far in Indiana as local units of government wrestle with how to make the most of the payments.
A decades-old federal program that offers doctors incentives to practice in disadvantaged communities has had little effect on physician density or patient mortality, a recent analysis concludes.
The research is the first to document that an obesity medication can not only pare pounds, but also safely prevent a heart attack, stroke or a heart-related death in people who already have heart disease—but not diabetes.
Abortion providers and a pregnancy resource center sought a preliminary injunction Thursday to broaden the scope of a health or life exception to Indiana’s near-total abortion ban and to expand the sites where the procedures can be performed.
The e-commerce giant says its Prime customers can now get quick access to a health care provider through a program that costs $9 a month or $99 annually.
